Estonia vs Guatemala: The number of people with susceptibility test result for rifampicin
Estonia
96.1
in 2021
Guatemala
95.02
in 2021
Estonia rank
48th
Guatemala rank
51st
The number of people with susceptibility test result for rifampicin over time
- Estonia
- Guatemala
How they compare
Estonia currently reports 96.1 against 95.02 in Guatemala, a difference of 1.08.
Across all 5 years both countries report, Estonia has been ahead every year.
Estonia ranks 48th and Guatemala ranks 51st of 146 countries.
Estonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 99.41 | 43.35 | 56.06 | Estonia |
| 2020s | 95.95 | 64.93 | 31.02 | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Estonia or Guatemala?
- Estonia, at 96.1 against 95.02 in Guatemala as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Estonia and Guatemala?
- 1.08, with Estonia ahead.
- How many years of comparable data are there for Estonia and Guatemala?
- 5 years are reported by both, from 2017 to 2021.
- How do Estonia and Guatemala rank globally for the number of people with susceptibility test result for rifampicin?
- Estonia ranks 48th and Guatemala ranks 51st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.